Status:
UNKNOWN
A Multicentered Prospective Cohort Study of Chinese IBD Patients
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Ulcerative Colitis
Crohn Disease
Eligibility:
All Genders
14-80 years
Brief Summary
Inflammatory bowel disease(IBD), including ulcerative colitis (UC) and Crohn's disease (CD), is characterized by chronic and recurrent nonspecific intestinal inflammation with high disability rate. Du...
Detailed Description
The research is aimed at exploring the mode of IBD progression and predicting prognosis of different IBD patients so that treatment choice could be made to get better efficacy and decrease economic bu...
Eligibility Criteria
Inclusion
- be diagnosed CD or UC according to Chinese consensus on diagnosis and treatment in inflammatory bowel disease(2018, Beijing)
- willing to be followed up
- intend to be treated by biological agents (VDZ, IFX or UST) or conventional drugs (glucocoticoid±immunosupressive drugs±5-ASA)
Exclusion
- with complex complications
Key Trial Info
Start Date :
July 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05386290
Start Date
July 9 2020
End Date
December 1 2023
Last Update
May 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100730